IN2 ASSESSEMENT OF THE ADDITIONAL COST OF DROTRECOGIN ALFA (ACTIVATED) RELATIVE TO STANDARD CARE IN THE TREATMENT OF SEVERE SEPSIS IN A MULTICENTIC OBSERVATIONAL STUDY IN FRANCE
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67200-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)67200-2/fulltext
Title :
IN2 ASSESSEMENT OF THE ADDITIONAL COST OF DROTRECOGIN ALFA (ACTIVATED) RELATIVE TO STANDARD CARE IN THE TREATMENT OF SEVERE SEPSIS IN A MULTICENTIC OBSERVATIONAL STUDY IN FRANCE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67200-2&doi=10.1016/S1098-3015(10)67200-2
First page :
Section Title :
Open access? :
No
Section Order :
356